More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to ...

Obesity has been an ongoing struggle for many consumers, and for years, body mass index (BMI) has been the key metric health ...

The Lancet, a global medical journal that works with academics to identify issues in public health, hosted a Commission on ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...